MA23.02 Circulating Tumor DNA Analysis With a Novel Variant Classifier for Recurrence Detection in Resected, Early-Stage Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.512
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

MA 13.01 Clinical and Pathological Variables Influencing Noninvasive Detection of Early Stage Lung Cancer Using Circulating Tumor DNA

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence

Clinical Cancer Research
Cancer ResearchOncology
2019English

Circulating Tumor DNA Analysis Detects Minimal Residual Disease and Predicts Recurrence in Patients With Stage II Colon Cancer

Science Translational Medicine
Medicine
2016English

Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling

Cancer Discovery
Oncology
2017English

Utility of Circulating Tumor DNA in Cancer Diagnostics With Emphasis on Early Detection

BMC Medicine
Medicine
2018English

Circulating Tumor DNA Detectable in Early- And Late-Stage Colorectal Cancer Patients

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2018English

Circulating Tumor DNA Detection in Lung Cancer Patients Before and After Surgery

Scientific Reports
Multidisciplinary
2016English

Circulating Tumor Cells as a Screening and Diagnostic Marker for Early-Stage Non-Small Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2020English

A Novel Virtual Barcode Strategy for Accurate Panel-Wide Variant Calling in Circulating Tumor DNA

BMC Bioinformatics
BiochemistryApplied MathematicsComputer Science ApplicationsStructural BiologyMolecular Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy